Brian Kennon, Mary C Ingram, Elaine C Friel, Niall H Anderson, Scott M MacKenzie, Eleanor Davies, Loai Shakerdi, A Michael Wallace, Robert Fraser, John M C Connell
Index: Clin. Endocrinol. (Oxf.) 61(2) , 174-81, (2004)
Full Text: HTML
Aldosterone synthase, a key enzyme in the terminal steps of aldosterone synthesis, is encoded by the CYP11B2 gene. A polymorphism in the 5' coding region of this gene (-344 C/T) is associated with hypertension, particularly with elevation of the aldosterone to renin ratio. A second polymorphism (a conversion in intron 2 to resemble that of the neighbouring 11beta-hydroxylase (CYP11B1) gene) is found in close linkage dysequilibrium with the variant at -344 C/T. The mechanism by which these variants predispose to cardiovascular disease and the precise intermediate phenotype associated with them remains speculative.We performed a focused physiological study in normal volunteers stratified by CYP11B2 genotype.Twenty-three subjects homozygous for the T allele and 21 homozygous for the C allele of the -344 C/T polymorphism of CYP11B2 were studied.Basal and angiotensin II stimulated plasma and 24-h urinary steroid excretion during low (60 mmol/day) and high (160 mmol/day) sodium intake and plasma steroids after ACTH stimulation were measured.No influence of polymorphic variation on basal or stimulated plasma cortisol or aldosterone or other plasma steroid concentrations during either dietary phase was seen. However, excretion of tetrahydro-11-deoxycortisol (the urinary metabolite of 11-deoxycortisol), which is the precursor of cortisol) was increased in TT subjects during sodium restriction, consistent with impairment of zona fasciculata 11beta-hydroxylation.We conclude that this polymorphism has no major influence on normal zona glomerulosa function but is associated with a change in 11beta-hydroxylation in the zona fasciculata. The mechanism remains uncertain, but alteration of 11-deoxycortisol levels without change in cortisol suggests altered efficiency of 11beta-hydroxylation. In the long term, this may lead to a minor but chronic increase in ACTH drive to the gland, which may have consequences for steroid synthesis and predispose to the risk of cardiovascular disease.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Tetrahydro-11-deoxy Cortisol
CAS:68-60-0 |
C21H34O4 |
|
Study of urinary steroid hormone disorders: difference betwe...
2014-07-01 [Anal. Bioanal. Chem 406(18) , 4325-35, (2014)] |
|
[Urinary tetrahydro-11-deoxycortisol].
2010-07-01 [Nihon Rinsho. 68 Suppl 7 , 401-3, (2010)] |
|
A quantitative in vivo mouse model used to assay inhibitors ...
1991-02-15 [Cancer Res. 51(4) , 1339-44, (1991)] |
|
Potent inhibitory effects of steroids in an in vitro model o...
1996-09-01 [J. Endocrinol. 150(3) , 457-64, (1996)] |
|
In the ventral tegmental area, progestins' membrane-mediated...
2006-01-01 [Neuroendocrinology 84(6) , 405-14, (2006)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
